Amphora Medical is developing a cystoscopic device to address Overactive Bladder Syndrome by treating the bladder nerves. A targeted fulguration procedure dampens nerve signals, with the potential to restore normal bladder function and provide lasting improvement. The therapy is currently under clinical investigation for Overactive Bladder syndrome and is not yet commercially available.

Transform Trial a new clinical research study: now enrolling     Learn more